nct02637284 bpc-157 results published Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights Gastric pentadecapeptide body protection compound
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing Cell and Tissue Research Springer Nature Link BPC 157: A Prohibited Peptide and an Unapproved Drug Found in Health and Wellness Products BPC 157, There are currently no published randomized controlled trials (RCTs) of BPC 157 in humans. All existing evidence comes from preclinical animal studies, primarily in rodent models., The A human BPC 157 trial was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo controlled clinical trial (NCT02637284) was launched
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

